Bookbuilding IPO | ₹570 Cr | Listed at BSE, NSE | Thu, Dec 21, 2023 - Tue, Dec 26, 2023
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
Innova Captab Limited peer comparison with similar listed entities. (As on March 31, 2023)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | Closing price as on period ended | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|---|
| Innova Captab Limited | 14.16 | 14.16 | 57.60 | 24.58 | Consolidated | |||
| Torrent Pharmaceuticals Limited | 36.79 | 36.79 | 182.97 | 57.61 | 20.11 | 2,119.65 | 11.58 | Consolidated |
| Laurus Labs Limited | 14.69 | 14.64 | 74.92 | 25.53 | 19.74 | 373.70 | 4.99 | Consolidated |
| Ajanta Pharma Limited | 45.89 | 45.89 | 267.41 | 42.91 | 17.36 | 1,969.15 | 7.36 | Consolidated |
| J. B. Chemicals and Pharmaceuticals Limited | 53.00 | 52.34 | 320.36 | 28.61 | 16.54 | 1,497.30 | 4.67 | Consolidated |
| NATCO Pharma Limited | 39.18 | 39.18 | 264.21 | 19.90 | 14.84 | 779.55 | 2.95 | Consolidated |
| Eris Lifesciences Limited | 28.10 | 28.07 | 160.85 | 33.01 | 17.10 | 926.70 | 5.76 | Consolidated |
| Indoco Remedies Limited | 15.44 | 15.42 | 111.58 | 22.74 | 13.83 | 350.70 | 3.14 | Consolidated |
| Suven Pharmaceuticals Limited | 16.16 | 16.16 | 68.16 | 37.13 | 23.70 | 600.05 | 8.80 | Consolidated |
| Windlas Biotech Limited | 19.70 | 19.70 | 192.02 | 22.04 | 10.61 | 434.25 | 2.26 | Consolidated |
Note:
All the financial information for listed industry peers mentioned above is on a consolidated basis and is sourced from the annual reports as available of the respective company for the year ended March 31, 2023. The information for Innova Captab Limited has been sourced from the Restated Consolidated Financial Information for the year ended March 31, 2023.
The financial parameters above are not reclassified by CRISIL and taken as reported by players.
Closing Price has been taken as of November 21, 2023
Hence, the comparison should not be made with the tables in the rest of the competitive section of the "Industry Overview" section.
The financial parameters are calculated as described below:
Net worth = Equity share capital + Other equity-capital reserves
NAV per share = Net worth / Number of equity shares outstanding R
eturn on net worth = PAT / Net worth
Innova Captab IPO Reviews, analysis and views by popular members.
| Review By | Apply | May Apply | Not Rated | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
